| Lam Pharmaceutics Limited |
| Registered Number:SC684503 |
For the year ended 31 December 2024
Scotland
Unaudited Financial Statements
For the year ended 31 December 2024
Lam Pharmaceutics Limited
Contents Page
1 to 2
Statement of Financial Position and Notes to the Accounts
Lam Pharmaceutics Limited
Statement of Financial Position and Notes to the Accounts
2023
2024
2,038
3,057
10,572
15,101
| Creditors: amounts falling due |
(10,104)
(3,133)
4,997
7,439
Net current assets
| Total assets less current liabilities |
9,477
8,054
| Accruals and deferred income |
(2,839)
(7,579)
6,638
Net assets
475
6,638
475
Statutory Information
| Lam Pharmaceutics Limited is a private limited company, limited by shares, domiciled in Scotland, registration number |
| SC684503. |
16 Priorwood Road
Newton Mearns
Glasgow
G77 6ZZ
| The presentation currency is £ sterling. |
| 1. Directors' advances, credits and guarantees |
| Year ended 31 December 2024 Control: |
| Mr Kar Tueng Jonathan Lam is the Company's controlling party. |
| Related party relationships and transactions: |
| During the year ended 31 December 2024, Mr Lam received dividends of £6400. |
| 2. Average number of persons employed |
During the year the average number of employees was 1 (2023 : 1)
1 of 2
For the year ended 31 December 2024
Lam Pharmaceutics Limited
Statement of Financial Position and Notes to the Accounts Continued
| For the year ended 31 December 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies. |
| The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006. |
| The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each |
| financial year and of its profit or loss for each financial year in accordance with the requirements of Section 394 and 395 and |
| which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as |
| applicable to the company. |
| These financial statements have been prepared in accordance with the micro-entities provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime. |
| Mr Kar Tueng Jonathan Lam Director |
| These financial statements were approved and authorised for issue by the Board on 25 September 2025 and were signed by: |
2 of 2